But what more and more patients and clinicians are coming to discover is that Ketamine infusions are showing many promising results as the go-to therapy to treatment-resistant depression.
Following weeks of shock therapy, patients are often then placed on one to several specific antidepressant medications while transitioning from their inpatient therapy to more of an outpatient management style of oversight.
Unlike the slower subjective effects of ECT, Ketamine appears to have a much more rapid and robust anti-depressant effect (aside from the fact that patients are actually conscious during the treatment as opposed to ECT).
Ketamine treatment is also cheaper in comparison to ECT in regard to receiving the actual treatment and not having to take off work for the periods of time required for ECT therapy.
Even though patients may still need to continue their anti-depressant medication for some time following Ketamine treatment (similar to ECT), Ketamine still appears to be the front runner in regard to the effectiveness of treating depression and the lack of disruption to the patient's life to receive the treatment itself.
There is also current research supporting the use of ketamine for rapid recovery from depressive symptoms and shows that Ketamine can provide a less invasive option for depressed patients, especially when a rapid response is desired.
Many researchers are looking to back this effort as well by setting up new trials testing Ketamine's efficacy in comparison to the burdensome treatment process of ECT.
Currently, Ketamine infusions are showing benefits and promise for treating severe depression, PTSD, and anxiety.
If you or someone you know has experienced ECT therapy with no improvement or are looking to try other effective depression treatment avenues prior to resorting to ECT therapy, click below and learn more about Ketamine infusions to improve or treat your depressive symptoms.
When facing a situation that few have done before, there are usually more questions than answers. Ketamine as a treatment for depression, especially TRD, is still in its infancy....